Orphazyme H1 Net Loss Bigger Than Expected; Operating Loss Outlook Unchanged

(PLX AI) – Orphazyme half year net income DKK -463.8 million vs. estimate DKK -405 million.Outlook FY operating loss DKK 670-700 million (unchanged) Orphazyme recognized net revenue of DKK 13.2 million from the sale of arimoclomol for treatment of …